logo BDSP

Base documentaire

Fermeture du portail BDSP le 1er juillet 2019. En savoir plus...

  1. Drug-induced hepatic injury : Molecular biology, pathogenesis and clinics.

    Article, Communication - En anglais

    International Symposium on Hepatology. Taipei (TWN), 1996/11/30.

    Drugs and other chemical toxins account for less than 5% of cases of jaundice or acute hepatitis and fewer cases of chronic liver disease, but they are an important cause of more severe types of hepatic injury.

    Drug reactions produce an array of hepatic lesions that mimic all known hepatobiliary diseases ; this poses a diagnostic challenge for physicians and pathologists.

    Diagnosis of drug-induced hepatic injury is circumstantial, with positive rechallenge being the only factor that unequivocally implicates a particular agent.

    Nonetheless, other aspects of the temporal relationship between drug ingestion and adverse reaction, exclusion of other diseases, the presence of extrahepatic features of drug hypersensitivity and some findings on liver biopsy can lend support to the diagnosis.

    Some of these issues will be explored in this review by considering contemporary paradigms of drug-induced hepatic injury.

    Factors that predispose to dose-dependent hepatic injury will be considered in relation to acetaminophen, an example of acute hepatotoxicity, and methotrexate, an agent that can produce hepatic fibrosis.

    Flucloxacillin will be discussed as an example of drug-induced cholestatic hepatitis often associated with prolonged cholestasis and the vanishing bile duct syndrome.

    Minocycline and diclofenac will be mentioned as two drugs for which drug hepatitis is an exceedingly rare complication.

    Finally, the evidence that Chinese herbal medicines can be hepatotoxic will be reviewed.

    Mots-clés Pascal : Chimiothérapie, Complication, Toxicité, Foie, Médicament, Diagnostic, Prévention, Epidémiologie, Homme, Pharmacovigilance, Appareil digestif pathologie, Foie pathologie

    Mots-clés Pascal anglais : Chemotherapy, Complication, Toxicity, Liver, Drug, Diagnosis, Prevention, Epidemiology, Human, Pharmacovigilance, Digestive diseases, Hepatic disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0003576

    Code Inist : 002B02U04. Création : 17/04/1998.

Fermeture du portail BDSP le 1er juillet 2019

Nous avons le regret de vous informer de la fermeture du portail BDSP le 1er juillet 2019. Du 1er janvier au 30 juin 2019, le site et ses services resteront accessibles mais ne seront plus alimentés, ni mis à jour. En savoir plus...